NCT00115635View on ClinicalTrials.gov

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

July 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

docetaxel

DRUG

gemcitabine

Trial Locations (1)

2730

Dept. of Oncology, 54B1, Herlev Hospital, Herlev

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

Herlev Hospital

OTHER